Skip to main content
. 2013 Jan-Feb;20(1):193–198. doi: 10.1136/amiajnl-2012-000948

Table 2.

Gender distribution across disease cases and data sources

MCO TDH
Male Female Male Female
n (%) n (%) n (%) n (%)
LD 372 (44.1%) 531 (58.8%) 124 (42.5%) 168 (57.5%)
RMSF 348 (52.6%) 313 (47.4%) 783 (56.6%) 601 (43.4%)
HME 7 (50.0%) 7 (50.0%) 238 (68.4%) 110 (31.6%)
Tularemia 26 (61.9%) 16 (38.1%) 23 (79.3%) 6 (20.7%)
LACV 9 (90.0%) 1 (10.0%) 39 (65.0%) 21 (35.0%)
WNV 10 (47.6%) 11 (52.4%) 31 (67.4%) 15 (32.6%)
Totals* 772 (46.8%) 779 (53.2%) 1238 (57.3%) 921 (42.7%)
*

6 TDH cases had unknown gender.

HME, human monocytic ehrlichiosis; LACV, La Crosse viral encephalitis; LD, Lyme disease; MCO, managed care organization; TDH; Tennessee Department of Health; RMSF, Rocky Mountain spotted fever; WNV, West Nile virus.